share_log

PharmaCyte Biotech | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Iroquois Master Fund Ltd.(4.99%),Iroquois Capital Management, LLC(4.99%), etc.

PharmaCyte Biotech | SC 13D/A:超過5%持股股東披露文件(修正)-Iroquois Master Fund Ltd.(4.99%),Iroquois Capital Management, LLC(4.99%)等

SEC announcement ·  2023/06/16 17:22
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息